Evaluation of metformin’s effect on 5-fluorouracil-induced cardiotoxicity through cellular protection
Authors:
- Nahlah Fahad AlreshidiNANahlah Fahad Alreshidi
- Reham Abdullah Al-DhelaanRAReham Abdullah Al-Dhelaan
- Amjad YousufAYAmjad Yousuf
- Nihal AlmuraikhiNANihal Almuraikhi
- Helal G. AlanaziHAHelal G. Alanazi
- Thamer AlsufayanTAThamer Alsufayan
- Musaad B. AlsahlyMAMusaad B. Alsahly
- Malik Bader AlazzamMalik Bader Alazzam
- 4 February 2026
- journal article
- research article
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 34 (1) , 11
Abstract
Background 5-Fluorouracil (5-FU) is a chemotherapeutic agent used primarily to treat various cancers. While it has been successful in improving cancer survival rates, 5-FU is also known to be cardiotoxic. Treatment options for patients experiencing 5-FU-induced cardiotoxicity are limited to standard heart failure medications. Objectives This study aims to investigate how metformin can reduce oxidative stress, apoptosis, and mitochondrial dysfunction in human cardiac myocyte (HCM) cells. Methods The optimal doses of 5-FU were determined using the MTT assay. Following exposure to 5-FU, HCM cells were treated with metformin for 48 h. The study measured the levels of reactive oxygen species (ROS), glutathione (GSH), and the activity of superoxide dismutase (SOD). Additionally, cytochrome c release and mitochondrial membrane potential were assessed in HCM cells. The expression levels of BAX and Bcl-2 were also examined, along with the activity of Caspase-3. Results The findings indicated that 5-FU significantly increased ROS levels, decreased GSH levels, and reduced SOD activity—effects that were mitigated by metformin. Furthermore, 5-FU markedly increased apoptosis and induced mitochondrial dysfunction, both of which were significantly reduced by metformin in a dose-dependent manner in HCM cells. Conclusion According to the present study results, metformin, through a reduction in oxidative stress, apoptosis, and mitochondrial malfunction, can have therapeutic potential in HCM cells toxicity induced by 5-FU.Keywords
This publication has 42 references indexed in Scilit:
- Emerging uncertainty on the anti-aging potential of metforminAgeing Research Reviews, 2025
- Pharmacological characterization of the antidiabetic drug metformin in atherosclerosis inhibition: A comprehensive insightImmunity, Inflammation and Disease, 2024
- The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled StudyDrug Safety, 2023
- Naringin ameliorates 5-fluorouracil induced cardiotoxicity: An insight into its modulatory impact on oxidative stress, inflammatory and apoptotic parametersTissue and Cell, 2023
- Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeuticsGenes & Diseases, 2022
- Assessment of cytotoxic effects of new derivatives of pyrazino[1,2-a] benzimidazole on isolated human glioblastoma cells and mitochondriaLife Sciences, 2021
- The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical studyLife Sciences, 2021
- Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via the MAPK and AMPK pathwaysLife Sciences, 2020
- Cardiotoxicities of 5-Fluorouracil and Other FluoropyrimidinesCurrent Treatment Options in Oncology, 2020
- Measurements of the Antioxidant Enzyme Activities of Superoxide Dismutase, Catalase, and Glutathione Peroxidase2007